Roundup Cancer Lawsuit News

Roundup Lawsuits Probe EPA-Monsanto Relationship

Roundup cancer lawsuits filed against Monsanto have called into question the company's relationship with the EPA that resulted in the allegedly chemical glyphosate to be approved by the agency.

Friday, March 17, 2017 - The presence of the EPA in Roundup lawsuits has been growing as the allegations begin to focus more heavily on the connection between Monsanto and the federal agency early in the process of the approval for the main ingredient glyphosate. The relationship between Monsanto and the testing agencies the EPA relied on to approve glyphosate has been described in many Monsanto Roundup cancer lawsuits as a process that included fraud and a lack of due diligence by the EPA.

Plaintiffs that have filed Roundup cancer lawsuits against Monsanto claim that the company first became aware of the carcinogenic properties behind glyphosate in the 1980's, and in 1985 the EPA declared the glyphosate was possibly carcinogenic to humans. Only six years later, however, the EPA declared that glyphosate was not carcinogenic, despite the objections of two committee members in charge of making the distinction. One of them even refused to sign off on the declaration.

In the same year as glyphosate was determined not to be toxic by the EPA, the first pieces of evidence were being published proving that glyphosate in complex chemical solutions could be more toxic than the chemical on its own. This was followed by a number of studies over the next 25 years that linked glyphosate to cancer and built the case for the chemical is a dangerous carcinogen. All this information would have been available to Monsanto, and plaintiffs believe that the company chose not to pass these warnings onto consumers in an effort to protect the marketability of their popular weed killer product.

Plaintiffs have claimed that Monsanto had been aware of the carcinogenic elements of their Roundup products for decades but decided to choose the profits that the popular weedkiller brought in over the overall health of the consumers and commercial farmers that used the product. The claims have singled out non-Hodgkin's lymphoma as main cancer that Roundup is linked to. The Roundup lawsuits have tied the company to the fraudulent procurement of data regarding glyphosate in the past, claiming the company pushed a dangerous chemical through the EPA vetting process with fake numbers in order to turn a profit.

Since that time multiple medical studies have surfaced linking glyphosate to cancer, and the allegations presented in the Monsanto Roundup lawsuits focus on the fact that the company was aware of these connections and pushed testing companies to instead file good reports related to glyphosate to the EPA. The nature of the reports did not fit into the story that has since been solidified through numerous studies into glyphosate.

The EPA has been included in recent Monsanto Roundup lawsuits because plaintiffs feel the federal agency did not vet the results they were given thoroughly enough, especially given the ties between Monsanto and the companies from which they received the results. The Roundup attorneys for the plaintiffs feel that the EPA bears responsibility for cancer causing glyphosate chemical's widespread exposure and the detrimental effect it had on those who used it. There has yet to be a trial involving either the EPA or Monsanto as the claims at this stage remain in the pretrial proceedings phase of litigation.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.